BeOne Medicines (ONC) Shares Outstanding (Weighted Average) (2015 - 2020)

BeOne Medicines (ONC) has 5 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.0 billion in Q1 2020.

• Quarterly Shares Outstanding (Weighted Average) changed N/A year-over-year to $1.0 billion in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $1.0 billion (changed N/A YoY) and the FY2018 annual result came in at $720.8 million, up 32.69% from the prior year.
• Shares Outstanding (Weighted Average) climbed to $1.0 billion in Q1 2020 per ONC's latest filing, from $720.8 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $1.0 billion in Q1 2020 and bottomed at $294.0 million in Q1 2016.
• The 4-year median for Shares Outstanding (Weighted Average) is $522.5 million (2017), against an average of $561.6 million.
• The widest annual swing landed in 2016, when Shares Outstanding (Weighted Average) jumped 294.16%; it then grew 21.02% in 2017.
• Tracing ONC's Shares Outstanding (Weighted Average) over 4 years: stood at $403.6 million in 2016, then surged by 34.58% to $543.2 million in 2017, then surged by 32.69% to $720.8 million in 2018, then surged by 39.49% to $1.0 billion in 2020.
• Per Business Quant, the three latest ONC Shares Outstanding (Weighted Average) figures stand at $1.0 billion (Q1 2020), $720.8 million (Q4 2018), and $684.6 million (Q2 2018).

Peer Comparison